skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
13375301
Filing Dt:
11/30/2011
Publication #:
Pub Dt:
04/12/2012
Inventors:
Kenneth E. Bernstein, Chentao Lin
Title:
USE OF ANGIOTENSIN CONVERTING ENZYME (ACE) DOMAIN SPECIFIC INHIBITORS TO INHIBIT OR ENHANCE CYTOKINE PRODUCTION AND ALTER IMMUNE RESPONSE
Assignment: 1
Reel/Frame:
027298/0932Recorded: 11/30/2011Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
06/04/2010
Exec Dt:
06/04/2010
Assignee:
8700 BEVERLY BOULEVARD
LOS ANGELES, CALIFORNIA 90048
Correspondent:
DAVIS WRIGHT TREMAINE LLP/LOS ANGELES
865 FIGUEROA STREET
SUITE 2400
LOS ANGELES, CA 90017-2566
Assignment: 2
Reel/Frame:
033888/0957Recorded: 10/03/2014Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
09/19/2014
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 3
Reel/Frame:
041533/0068Recorded: 03/09/2017Pages: 4
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/09/2017
Assignee:
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
BETHESDA, MARYLAND 20892-7980
Correspondent:
PATTY PIERSON
8727 W. 3RD STREET, SUITE 203
METRO-203
LOS ANGELES, CA 90048

Search Results as of: 06/23/2024 10:32 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT